GIP and metabolic dysfunction-associated steatohepatitis: There is also the stimulation of gut hormones, as GLP1, GIP, and food intake inhibition by SCFAs may represent a novel mechanism by which GM regulates the pathological progression of NAFLD to NASH [12].